Minerva urology and nephrology
YAU-RCC spotlight: dual VEGF/EGFR blockade shows promise for reshaping the treatment of papillary RCC in hereditary leiomyomatosis and renal cell cancer syndrome.
Selcuk Erdem, Murat Sari, Laura Marandino, Ronan Flippot, Daniele Amparore, Riccardo Campi, European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group
Published: 202510.23736/S2724-6051.25.06707-2
No abstract available for this study.